Wednesday, June 10, 2026

biotech Β· Advanced Solid Tumors Β· Seasonal Allergic Rhinitis Β· PRME

Prime Medicine

Prime Medicine clinical programs β€” 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

60 First St, Cambridge, Massachusetts 02141, US HQ
2019 Founded
185 Employees
Public company Type
PRME Β· NYSE Ticker
Company details
Status
Public
HQ
60 First St, Cambridge, Massachusetts 02141, US
Founded
2019
Employees
185
Programs
17
Drugs
6
Patents
127
Intelligence Β· Clinical Programs

Prime Medicine projects

3 ClinicalTrials.gov programs sponsored by Prime Medicine.

Prime Medicine has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. PG-011 nasal spray 0.6%(twice daily)

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial
  2. PG-011Gel

    Prime Medicine

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial
  3. Recommended treatment schedule

    Prime Medicine

    COVID-19

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Prime Medicine have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.